XML 111 R82.htm IDEA: XBRL DOCUMENT v3.24.2.u1
License Agreements (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 21, 2024
Apr. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenue     $ 0 $ 15,000
Sale of stock, number of shares issued (in shares) 15,409,102      
Sale of stock, consideration received $ 53,500      
Ji Xing Pharmaceuticals Hong Kong Limited        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Revenue       $ 15,000
Ji Xing Pharmaceuticals Hong Kong Limited | License revenue        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Contract with customer, liability   $ 15,000    
Revenue, remaining performance obligation, variable consideration amount   $ 95,000    
License Agreement, Significant Investor | Series A-1 Convertible Preferred Stock        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Sale of stock, number of shares issued (in shares)   2,950,548    
Sale of stock, consideration received   $ 10,000